Cite

HARVARD Citation

    Himedan, M. et al. (2017). Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment. Journal of investigative medicine high impact case reports. p. . [Online]. 
  
Back to record